$59 billion publicly held multinational biopharmaceutical company applying science and global resources to improve health and well-being at every stage of life.Responsible for investment, debt, derivative and insurance accounting and disclosures.

Provide technical accounting and broader risk impact analyses on acquisitions, investments, divestitures, licensing arrangements, collaborations and R&D financing arrangements.

$152 billion publicly held multinational automotive and finance company that designs, manufactures, markets and finances vehicles and automobile parts worldwide.Sole member of global M&A accounting team based in New York Treasurer's Office. Provide technical accounting and risk impact analysis on complex transactions. Work closely with legal, tax, accounting, and deal teams to identify and resolve issues. Technical accounting issues included consolidation and variable interest entities (ASC 810/SFAS 167/EITF 04-5), transfers of financial assets and servicing (ASC 860/SFAS 166), fair value accounting (ASC 820/SFAS 157), and business combinations (ASC 805/SFAS 141r).Key achievementsPrimary accounting project manager supporting diligence on $4.2 billion acquisition of Ally Financial's international auto finance operations and $3.8 billion sale of GM's stake in Delphi Conducted variable interest entities analyses for securitization structures, loan participation agreements, investments and troubled supplier arrangementsEstablished M&A Accounting function at New York Treasurer's Office

$365 million publicly-held multinational Science-based Company that develops, manufactures and markets prescription and Over-the-Counter (OTC) pharmaceutical products primarily in the U.S., Canada and Israel.Reporting to the Chief Financial Officer, led SEC reporting process. Reviewed and approved all journal entries prepared by Divisional Controllers for accuracy and appropriate accounting treatment under GAAP. Provided technical accounting research guidance to Chief Financial Officer. Key achievementsCreated new process for preparing, reviewing and documenting journal entries at subsidiaries representing approximately 90% of the company’s consolidated revenue.Created accounting policy function at company for analyzing new accounting standardsRevised key disclosures in SEC filings, such as Critical Accounting Policies and Quantitative and Qualitative Disclosures about Market RiskSuccessfully implemented ASC 820/SFAS 157 and ASC 740-10/FIN 48

$1.9 billion NYSE provider of credit ratings; credit / economic related research, data / analytical tools; risk management software, and quantitative credit risk measures and credit portfolio management solutions.Analyzed debt covenants and published related research in a subscription service for buy-side analysts. Managed issuer relationships with corporate treasurers at Fortune 500 companies. Served as accounting and financial expert in a team of attorneys.Key achievementsSet policy for merger covenants using different financial ratio tests. Published related research in a timely manner, which improved the effectiveness of the policy and enhanced the reputation of the service.Designed process for estimating complex debt compliance calculation, which reduced analyst time spent on calculations by approximately 50% and increased the accuracy of the estimates.Identified and solved numerous complex financial and credit issues in sale / leaseback covenants.

Provided analysis, opinion and feedback in support of analysts in the assessment of credit risk for a portfolio of U.S. and foreign based public companies with total debt in excess of $100 billion. Provided technical accounting guidance to credit analysts using numerous standards, such as SFAS 158, SFAS 133, SFAS 141, SFAS 142, SFAS 144, SFAS 109, SFAS 115, FIN 48, and FIN 46r. Reported to the Managing Director.Key achievementsAuthored and published accounting research, including the ratings impact of Section 404 of the Sarbanes-Oxley Act that was referenced in a Wall Street Journal Editorial and other business publications.Designed methodology for evaluating the quality of public disclosure for wholesale power and regulated utilities. Methodology was used in published research and in credit analysis.Identified and resolved improper pension cost treatment issues on several Fortune 500 Cash Flow StatementsProvided insight and analysis as a key member of a team evaluating the credit impact of pension immunization and liability driven investment strategies.Acted as accounting expert in ratings-related meetings with executive management of Fortune 500 companies.Presented and publicly spoke to small and large groups on accounting and credit related subjects.

$11 billion NYSE Diversified Energy Holding Company and leading National Wholesale Energy Producer.Researched, analyzed, and solved complex technical accounting issues. Prepared SEC filings and met the company’s accelerated filing deadlines. Prepared cash flow statements, footnotes, MD&A, and non-financial parts of SEC filings. Reviewed consolidations and general accounting entries. Resolved accounting issues with external auditors and SEC Comment Letters.Key achievementsLed company's adoption and implementation of FIN 46r and SFAS 150Primary accounting manager supporting diligence on $220 million acquisitionDesigned new accounting research and cash flow statement processes

Supervised senior and staff auditors on large and small audit engagements. Conducted audit procedures on complex and risky areas.